CONNECTIVE TISSUE RESEARCH

metrics 2024

Innovative Insights into Biomedical Connective Tissue Research

Introduction

CONNECTIVE TISSUE RESEARCH is a distinguished academic journal published by Taylor & Francis Inc, dedicated to the study of connective tissue within a broad spectrum of biomedical fields. Since its inception in 1972, this journal has emerged as a crucial platform for disseminating high-quality research findings, exploring fundamental and applied aspects of connective tissue biology. With its convergence stretching to 2024, CONNECTIVE TISSUE RESEARCH showcases innovative research in areas such as biochemistry, orthopedics, rheumatology, and cell biology, making significant contributions to our understanding of tissue structure and function. The journal holds a commendable impact factor and ranks notably in various categories, including a Q2 status in Biochemistry and Orthopedics, reflecting its pivotal role in advancing knowledge in these fields. Researchers and professionals can benefit from its offerings, which include original articles, reviews, and cutting-edge studies, all aimed at enhancing scientific inquiry and clinical applications. The journal remains committed to promoting accessibility through traditional subscription options, ensuring its wide reach in the academic community.

Metrics 2024

SCIMAGO Journal Rank0.75
Journal Impact Factor2.80
Journal Impact Factor (5 years)3.30
H-Index79
Journal IF Without Self2.80
Eigen Factor0.00
Normal Eigen Factor0.42
Influence0.77
Immediacy Index0.40
Cited Half Life8.80
Citing Half Life7.80
JCI0.83
Total Documents1321
WOS Total Citations2799
SCIMAGO Total Citations8667
SCIMAGO SELF Citations172
Scopus Journal Rank0.75
Cites / Document (2 Years)2.87
Cites / Document (3 Years)2.84
Cites / Document (4 Years)2.97

Metrics History

Rank 2024

Scopus

Orthopedics and Sports Medicine in Medicine
Rank #36/321
Percentile 88.79
Quartile Q1
Rheumatology in Medicine
Rank #18/73
Percentile 75.34
Quartile Q1
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #165/438
Percentile 62.33
Quartile Q2
Molecular Biology in Biochemistry, Genetics and Molecular Biology
Rank #185/410
Percentile 54.88
Quartile Q2
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #141/285
Percentile 50.53
Quartile Q2

IF (Web Of Science)

CELL BIOLOGY
Rank 136/205
Percentile 33.90
Quartile Q3
ORTHOPEDICS
Rank 24/136
Percentile 82.70
Quartile Q1

JCI (Web Of Science)

CELL BIOLOGY
Rank 79/205
Percentile 61.46
Quartile Q2
ORTHOPEDICS
Rank 51/136
Percentile 62.50
Quartile Q2

Quartile History

Similar Journals

Cellular and Molecular Bioengineering

Advancing the Frontiers of Bioengineering Research
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

Tissue Engineering Part B-Reviews

Pioneering Reviews for Biomedical Breakthroughs.
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3368Frequency: 6 issues/year

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

CELL AND TISSUE RESEARCH

Fostering Excellence in Pathology and Forensic Medicine Research
Publisher: SPRINGERISSN: 0302-766XFrequency: 12 issues/year

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

CELL AND TISSUE BANKING

Connecting research and practice in cell and tissue banking.
Publisher: SPRINGERISSN: 1389-9333Frequency: 4 issues/year

CELL AND TISSUE BANKING, published by Springer, is a prominent journal dedicated to advancing the fields of biomaterials, biomedical engineering, cell biology, and transplantation. With its ISSN 1389-9333 and E-ISSN 1573-6814, the journal plays a crucial role in disseminating high-quality research from its inception in 2000 to its ongoing contributions through 2024. Situated in the Netherlands, it boasts a respectable 2023 impact factor with notable quartile rankings, positioning it within the Q3 category for biomaterials, biomedical engineering, and transplantation, and Q4 for cell biology. Furthermore, its Scopus rankings underscore its relevance and influence, particularly in the fields of medicine and engineering. Although it does not currently offer open access options, the journal remains a vital resource for researchers, professionals, and students alike, fostering innovation and knowledge transfer in the critical areas of cell and tissue sustainability.

Stem Cells International

Exploring Breakthroughs in Stem Cell Technology
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Journal of Orthopaedic Translation

Bridging the gap between science and surgery for better health.
Publisher: ELSEVIERISSN: 2214-031XFrequency: 4 issues/year

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

CELLS TISSUES ORGANS

Exploring the Intricacies of Cells, Tissues, and Organs.
Publisher: KARGERISSN: 1422-6405Frequency: 6 issues/year

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

Tissue Engineering and Regenerative Medicine

Transforming Research into Revolutionary Therapeutic Strategies
Publisher: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOCISSN: 1738-2696Frequency: 6 issues/year

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

TISSUE & CELL

Connecting Research to Real-World Impact
Publisher: CHURCHILL LIVINGSTONEISSN: 0040-8166Frequency: 6 issues/year

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

Journal of Tissue Engineering

Exploring Innovations in Biomaterials and Beyond
Publisher: SAGE PUBLICATIONS INCISSN: 2041-7314Frequency: 1 issue/year

The Journal of Tissue Engineering, published by SAGE Publications Inc., stands at the forefront of innovation in the interdisciplinary fields of biomaterials and biomedical engineering. Established as an open access journal since 2010, it has quickly ascended to a leading position, as evidenced by its impressive rankings in 2023: Q1 in Biomaterials, Q1 in Biomedical Engineering, and Q1 in Medicine (miscellaneous). With a current impact factor that underscores its academic influence, this journal provides a vital platform for researchers, professionals, and students to share groundbreaking discoveries and advancements in tissue engineering and regenerative medicine. Located in the United Kingdom, the journal fosters a global dialogue with its robust publications and rigorous peer-review process, contributing significantly to the enhancement and understanding of complex biological systems. Join the esteemed community of thought leaders and innovators shaping the future of healthcare through the Journal of Tissue Engineering.